The role of fungal infections in orthopaedics and trauma surgery
Conditions
Interventions
Group 1: Retrospective cohort of all patients with musculoskeletal mycotic infections who were treated at the University Hospital of Bonn between 2013 and 2025.
Sponsors
Universitätsklinikum Bonn
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Presence of a microbiologically confirmed fungal infection that was interpreted as clinically significant and treated accordingly.
Exclusion criteria
Exclusion criteria: Insufficient data to assess the outcome and lack of possibilities to contact the patient.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Retrospective, single-center study over a 13-year period. Primary endpoints: - Infection-free survival following surgical treatment of a musculoskeletal mycotic (fungal) infection - Microbiological spectrum of pathogens in such infections, including characterization of the common bacterial co-pathogens involved | — |
Secondary
| Measure | Time frame |
|---|---|
| - Identification of risk factors that predispose to mycotic infection of the musculoskeletal system | — |
Countries
Germany
Contacts
Public ContactFrank Sebastian Fröschen
Universitätsklinikum Bonn
Outcome results
None listed